ARCHIVES

Roswell Park Researchers Win $1.6M For Tobacco Studies.

This article is from The Cancer Letter archive.

Vol. 29 No. 25 | June 20, 2003

Download PDF Visit The Full Archive

Related Articles

BRAF Inhibitor Shrank Tumors In Phase II Genentech Study

November 26, 2010

FDA News: Rep. Barton Expresses “Concern” About Plan To Merge Offices

May 22, 1998

Study Finds No Link Between Pill And Breast Cancer Risk

July 26, 2002

NCI Advisors Criticize Plan To Fund R01s On ESA Research With Amgen, J&J Money.

June 27, 2008

GlaxoSmithKline Partners With MD Anderson, Fred Hutchinson

December 14, 2012

Afinitor and Exemestane More Than Doubles PFS, Reduces Progression Risk by 57 Percent

September 30, 2011